Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 5/20 | 0.37 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.36 |
| ▸ | PLA2G5 | P39877 | 3/20 | 0.36 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.35 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ICMT | O60725 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | MME | P08473 | 1/20 | 0.31 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21596758 | 1.00 | ACE (0.37) | ACEPLA2G2APLA2G5NOD1HAO1 | |
| SCHEMBL21596751 | 0.86 | ZDHHC7 (0.34) | MAPTHDAC2 | |
| SCHEMBL21596750 | 0.86 | ZDHHC7 (0.34) | MAPTHDAC2 | |
| SCHEMBL28478998 | 0.81 | ACE (0.41) | ACEPLA2G2APLA2G5NOD1HAO1 | |
| SCHEMBL28478999 | 0.81 | ACE (0.41) | ACEPLA2G2APLA2G5NOD1HAO1 | |
| SCHEMBL21596754 | 0.79 | ACE2 (0.39) | ACEHAO1KMT2AMAPTFAAH | |
| SCHEMBL23531288 | 0.74 | EPHX1 (0.49) | HAO1KMT2AMAPTFAAHMEN1 | |
| SCHEMBL23531371 | 0.74 | EPHX1 (0.49) | HAO1KMT2AMAPTFAAHMEN1 | |
| SCHEMBL23531318 | 0.74 | EPHX1 (0.49) | HAO1KMT2AMAPTFAAHMEN1 | |
| SCHEMBL23531334 | 0.74 | EPHX1 (0.49) | HAO1KMT2AMAPTFAAHMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3746532-B1 | COMPOUNDS FOR PROVIDING A LONG-LASTING STRAWBERRY ODOR | FIRMENICH & CIE (CH) | 2022-02-23 | — | — | EP | disclosed |
| US-20210363461-A1 | COMPOUNDS FOR PROVIDING A LONG-LASTING STRAWBERRY ODOR | FIRMENICH SA (CH) | 2021-11-25 | — | — | US | disclosed |
| EP-3746532-A1 | COMPOUNDS FOR PROVIDING A LONG-LASTING STRAWBERRY ODOR | Firmenich SA (CH) | 2020-12-09 | — | — | EP | disclosed |
| WO-2019243369-A1 | COMPOUNDS FOR PROVIDING A LONG-LASTING STRAWBERRY ODOR | FIRMENICH SA (CH) | 2019-12-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210363461-A1 | COMPOUNDS FOR PROVIDING A LONG-LASTING STRAWBERRY ODOR | CUTA, TRPA1, COXFA4L2 | ACE 4554/4885PLA2G2A 3867/4885PLA2G5 4379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.